107 related articles for article (PubMed ID: 38542225)
1. Comprehensive studies on the biological activities of human metastatic (MDA-MB-231) and non-metastatic (MCF-7) breast cancer cell lines, directly or combinedly treated using non-thermal plasma-based approaches.
Terefinko D; Dzimitrowicz A; Bielawska-Pohl A; Pohl P; Klimczak A; Jamroz P
Toxicol In Vitro; 2024 Jun; 98():105846. PubMed ID: 38754599
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Cold Atmospheric Plasma vs. Chemotherapy in Triple-Negative Breast Cancer: A Systematic Review.
Almeida-Ferreira C; Marto CM; Carmo C; Almeida-Ferreira J; Frutuoso C; Carvalho MJ; Botelho MF; Laranjo M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542225
[TBL] [Abstract][Full Text] [Related]
3. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
[TBL] [Abstract][Full Text] [Related]
4. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
[TBL] [Abstract][Full Text] [Related]
5. Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.
Abdelhamed S; Yokoyama S; Refaat A; Ogura K; Yagita H; Awale S; Saiki I
Anticancer Res; 2014 Apr; 34(4):1893-9. PubMed ID: 24692724
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
[TBL] [Abstract][Full Text] [Related]
7. Chloroform Fraction of Methanolic Extract of Seeds of Annona muricata Induce S Phase Arrest and ROS Dependent Caspase Activated Mitochondria-Mediated Apoptosis in Triple-Negative Breast Cancer.
Kariyil BJ; Ayyappan UPT; Gopalakrishnan A; George AJ
Anticancer Agents Med Chem; 2021; 21(10):1250-1265. PubMed ID: 32951586
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Effect of Cold Atmospheric Plasma in Syngeneic Mouse Models of Melanoma and Colon Cancer.
Jung JM; Yoon HK; Kim SY; Yun MR; Kim GH; Lee WJ; Lee MW; Chang SE; Won CH
Molecules; 2023 May; 28(10):. PubMed ID: 37241912
[TBL] [Abstract][Full Text] [Related]
9. Current understanding of plasma-activated solutions for potential cancer therapy.
Yoshikawa N; Nakamura K; Kajiyama H
Free Radic Res; 2023 Feb; 57(2):69-80. PubMed ID: 36944223
[TBL] [Abstract][Full Text] [Related]
10. Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review.
Lu B; Natarajan E; Balaji Raghavendran HR; Markandan UD
Technol Cancer Res Treat; 2023; 22():15330338221145246. PubMed ID: 36601658
[TBL] [Abstract][Full Text] [Related]
11. Tumour cell heterogeneity in triple-negative breast cancer cells affects response to cisplatin, but not doxorubicin.
Yaourtis AM; Levina A; Lay PA
J Inorg Biochem; 2023 Feb; 239():112082. PubMed ID: 36459780
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series.
Cosar R; Sut N; Ozen A; Tastekin E; Topaloglu S; Cicin I; Nurlu D; Ozler T; Demir S; Yıldız G; Şenödeyici E; Uzal MC
Breast Cancer (Dove Med Press); 2022; 14():259-280. PubMed ID: 36105268
[TBL] [Abstract][Full Text] [Related]
13. Cold Atmospheric Plasma-Activated Media Improve Paclitaxel Efficacy on Breast Cancer Cells in a Combined Treatment Model.
Mihai CT; Mihaila I; Pasare MA; Pintilie RM; Ciorpac M; Topala I
Curr Issues Mol Biol; 2022 Apr; 44(5):1995-2014. PubMed ID: 35678664
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
